Cosmos Pharmaceutical's Nine-Month Profit Rises 1.8%

MT Newswires Live04-13 16:35

Cosmos Pharmaceutical's (TYO:3349) profit attributable to owners of the parent rose 1.8% to 22.8 billion yen for the nine months ended Feb. 28 from 22.3 billion yen a year earlier.

The pharmaceutical firm's basic earnings per share increased to 287.02 yen from 281.91 yen a year ago, according to a Tokyo bourse filing on Monday.

Net sales jumped 7.7% to 810.4 billion yen from 752.3 billion yen in the prior year.

For the fiscal year ending May 31, the company expects attributable profit of 31 billion yen, basic EPS of 391.13 yen, and net sales of 1.057 trillion yen.

Cosmos Pharmaceutical plans to pay a year-end dividend of 37.50 yen per share for the current year, bringing the total annual payout to 75 yen, which is higher than the 70 yen paid in the year-ago period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment